Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Haris Ali
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Haris Ali
205 views
June 14, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology